Danaher Corporation

NYSE DHR

Danaher Corporation Revenue for the Trailing 12 Months (TTM) ending September 27, 2024: USD 20.03 B

Danaher Corporation Revenue is USD 20.03 B for the Trailing 12 Months (TTM) ending September 27, 2024, a -32.25% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Danaher Corporation Revenue for the Trailing 12 Months (TTM) ending September 29, 2023 was USD 29.57 B, a -5.39% change year over year.
  • Danaher Corporation Revenue for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 31.25 B, a 11.35% change year over year.
  • Danaher Corporation Revenue for the Trailing 12 Months (TTM) ending October 01, 2021 was USD 28.07 B, a 37.63% change year over year.
  • Danaher Corporation Revenue for the Trailing 12 Months (TTM) ending October 02, 2020 was USD 20.39 B, a -0.22% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
NYSE: DHR

Danaher Corporation

CEO Mr. Rainer M. Blair
IPO Date Dec. 29, 1978
Location United States
Headquarters 2200 Pennsylvania Avenue, NW
Employees 61,000
Sector Health Care
Industries
Description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Similar companies

IDXX

IDEXX Laboratories, Inc.

USD 418.63

-0.94%

ILMN

Illumina, Inc.

USD 136.48

-5.37%

RVTY

Revvity, Inc.

USD 120.73

-1.61%

GH

Guardant Health, Inc.

USD 37.46

-1.68%

CRL

Charles River Laboratories International, Inc.

USD 178.08

-6.34%

WAT

Waters Corporation

USD 404.93

1.26%

A

Agilent Technologies, Inc.

USD 143.43

1.04%

TMO

Thermo Fisher Scientific Inc.

USD 556.99

0.27%

MTD

Mettler-Toledo International Inc.

USD 1.27 K

0.33%

StockViz Staff

January 15, 2025

Any question? Send us an email